 |
Previous Article | Next Article 
The Journal of Neuroscience, February 1, 2003, 23(3):955
Formation of Complement Membrane Attack Complex in Mammalian
Cerebral Cortex Evokes Seizures and Neurodegeneration
Zhi-Qi
Xiong1,
Weihua
Qian1,
Katsuaki
Suzuki1, and
James O.
McNamara1, 2, 3, 4
Departments of 1 Neurobiology, 2 Medicine
(Neurology), and 3 Pharmacology and Molecular Cancer
Biology, Duke University Medical Center, Durham, North Carolina 27710, and 4 Durham Veterans Affairs Medical Center, Durham, North
Carolina 27710
The complement system consists of >30 proteins that interact in a
carefully regulated manner to destroy invading bacteria and prevent the
deposition of immune complexes in normal tissue. This complex system
can be activated by diverse mechanisms proceeding through distinct
pathways, yet all converge on a final common pathway in which five
proteins assemble into a multimolecular complex, the membrane attack
complex (MAC). The MAC inserts into cell membranes to form a functional
pore, resulting in ion flux and ultimately osmotic lysis.
Immunohistochemical evidence of the MAC decorating neurons in cortical
gray matter has been identified in multiple CNS diseases, yet the
deleterious consequences, if any, of MAC deposition in the cortex of
mammalian brain in vivo are unknown. Here we demonstrate
that the sequential infusion of individual proteins of the membrane
attack pathway (C5b6, C7, C8, and C9) into the hippocampus of awake,
freely moving rats induced both behavioral and electrographic seizures
as well as cytotoxicity. The onset of seizures occurred during or
shortly after the infusion of C8/C9. Neither seizures nor cytotoxicity resulted from the simultaneous infusion of all five proteins premixed in vitro. The requirement for the
sequential infusion of all five proteins together with the temporal
relationship of seizure onset to infusions of C8/C9 implies that the
MAC was formed in vivo and triggered both seizures and
cytotoxicity. Deposition of the complement MAC in cortical gray matter
may contribute to epileptic seizures and cell death in diverse diseases
of the human brain.
Key words:
complement; membrane attack complex; C5b9; seizure; neurodegeneration; hippocampus; Fluoro-Jade B
Copyright © 2003 Society for Neuroscience 0270-6474/03/233955-06$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
Q. Chen, S. He, X.-L. Hu, J. Yu, Y. Zhou, J. Zheng, S. Zhang, C. Zhang, W.-H. Duan, and Z.-Q. Xiong
Differential Roles of NR2A- and NR2B-Containing NMDA Receptors in Activity-Dependent Brain-Derived Neurotrophic Factor Gene Regulation and Limbic Epileptogenesis
J. Neurosci.,
January 17, 2007;
27(3):
542 - 552.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Gorter, E. A. van Vliet, E. Aronica, T. Breit, H. Rauwerda, F. H. Lopes da Silva, and W. J. Wadman
Potential New Antiepileptogenic Targets Indicated by Microarray Analysis in a Rat Model for Temporal Lobe Epilepsy
J. Neurosci.,
October 25, 2006;
26(43):
11083 - 11110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Roll, G. Rudolf, S. Pereira, B. Royer, I. E. Scheffer, A. Massacrier, M.-P. Valenti, N. Roeckel-Trevisiol, S. Jamali, C. Beclin, et al.
SRPX2 mutations in disorders of language cortex and cognition
Hum. Mol. Genet.,
April 1, 2006;
15(7):
1195 - 1207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Jamali, F. Bartolomei, A. Robaglia-Schlupp, A. Massacrier, J.-C. Peragut, J. Regis, H. Dufour, R. Ravid, P. Roll, S. Pereira, et al.
Large-scale expression study of human mesial temporal lobe epilepsy: evidence for dysregulation of the neurotransmission and complement systems in the entorhinal cortex
Brain,
March 1, 2006;
129(3):
625 - 641.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Alexander, A. Jacob, L. Bao, R. L. Macdonald, and R. J. Quigg
Complement-Dependent Apoptosis and Inflammatory Gene Changes in Murine Lupus Cerebritis
J. Immunol.,
December 15, 2005;
175(12):
8312 - 8319.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Bien, T. Granata, C. Antozzi, J. H. Cross, O. Dulac, M. Kurthen, H. Lassmann, R. Mantegazza, J.-G. Villemure, R. Spreafico, et al.
Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: A European consensus statement
Brain,
March 1, 2005;
128(3):
454 - 471.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Watson, Y. Jiang, I. Bermudez, L. Houlihan, L. Clover, K. McKnight, J. H. Cross, I. K. Hart, A. Roubertie, J. Valmier, et al.
Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis
Neurology,
July 13, 2004;
63(1):
43 - 50.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Cowell, J. M. Plane, and F. S. Silverstein
Complement Activation Contributes to Hypoxic-Ischemic Brain Injury in Neonatal Rats
J. Neurosci.,
October 15, 2003;
23(28):
9459 - 9468.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|